2012
DOI: 10.1016/j.imlet.2012.05.001
|View full text |Cite
|
Sign up to set email alerts
|

CCR9+ plasmacytoid dendritic cells in the small intestine suppress development of intestinal inflammation in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
23
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(27 citation statements)
references
References 18 publications
3
23
1
Order By: Relevance
“…3E). In contrast to studies by Mizuno et al 36 who reported small bowel inflammation in Rag2 −/− Ccr9 −/− recipient mice that received WT CD45RB hi CD4 + T cells, ileitis was not observed in Rag1 −/− Ccl25 −/− recipient mice after T cell transfer (see Fig., Supplemental Digital Content 2, http://links.lww.com/IBD/A471). Together, incorporating the results from the last section, these data suggest that while CCR9 expression on T cells does not modulate T cell–mediated colitis in immunodeficient hosts, expression of CCL25 in recipient mice regulates the severity of T cell–mediated colitis development.…”
Section: Resultscontrasting
confidence: 80%
See 1 more Smart Citation
“…3E). In contrast to studies by Mizuno et al 36 who reported small bowel inflammation in Rag2 −/− Ccr9 −/− recipient mice that received WT CD45RB hi CD4 + T cells, ileitis was not observed in Rag1 −/− Ccl25 −/− recipient mice after T cell transfer (see Fig., Supplemental Digital Content 2, http://links.lww.com/IBD/A471). Together, incorporating the results from the last section, these data suggest that while CCR9 expression on T cells does not modulate T cell–mediated colitis in immunodeficient hosts, expression of CCL25 in recipient mice regulates the severity of T cell–mediated colitis development.…”
Section: Resultscontrasting
confidence: 80%
“…CCR9-expressing pDCs have been reported to home to small intestinal tissues in steady state and in the setting of intestinal inflammation and can modulate immune responses in extraintestinal sites. 3436 Mizuno et al observed that Rag2 −/− Ccr9 −/− recipient mice develop ileitis, as well as colitis, when transferred with WT CD45RB hi CD4 + T cells. 36 The authors attributed the ileitis to altered localization and function of regulatory pDCs within the small intestine of Rag2 −/− Ccr9 −/− recipient mice.…”
Section: Discussionmentioning
confidence: 99%
“…31,32 Collectively, these findings suggest that pDCs are required for initiation of DSS-induced colonic inflammation and tissue damage possibly mediated through the control of mucosal production of proinflammatory cytokines. On the other hand, Mizuno et al 39 have recently suggested that CCR9 þ pDCs in the small intestine (SI) suppress the development of murine spontaneous intestinal inflammation as CCR9 þ pDCs preferentially resided in the SI in the steady state, and Ccr9 À / À Rag-2 À / À mice developed more severe ileitis compared with Rag-2 À / À mice when these mice were adoptively transferred with CD4 þ CD45RB high T cells, although they did not assess the direct contribution …”
Section: Discussionmentioning
confidence: 98%
“…PDC contribute to peripheral T cell tolerance in transplantation(71), tumor escape(72), oral-(73) and mucosal tolerance(74). “Tolerogenic” pDC may be present in mouse gut and thymus(7577). Such pDC may express the chemokine receptor CCR9, that is lost upon TLR triggering correlating with reduced ability to prime tolerance(75).…”
Section: Tolerancementioning
confidence: 99%